Location: Home
  • search
  • go
  • Relate News
  • 4/15/2024NHSA: Over 11M Chinese Benefited from Critical Illness Insurance
  • 4/12/2024PhIIC: Review of Chinese Hospital Drug Market in 2023
  • 4/12/2024Review of Chinese Online Pharmacy Drug Sales and Leading Products in 2...
  • 4/12/2024Recent Executive Moves
  • 4/11/2024NHSA's 2023 Healthcare Security Sector Development Statistical Highlig...
  • 4/11/2024NHSA Disputes Claims of a 'Dropout Wave' in China's Basic Medical Insu...
  • 4/11/2024Out-of-Area Medical Bill Settlement Jumps Nearly Fourfold After BMI S...
  • 4/11/2024Drugmakers Race to Find Alternative Suppliers as US Cracks Down on Chi...
  • 4/11/2024Geopolitics Threatens Chinese Biotechs' Hot Out-licensing Biz (Fierce ...
  • 4/10/2024Biosimilars Coming into Their Own in China, Despite Concerns (Bioworld...
  • 4/10/2024Generic Drugs Has Experienced Falling Market Share Since 2018
  • 4/9/2024Broad Measures Outlined at the 2024 Natl Conference on Rectifying Viol...
  • 4/9/2024Chinese VMS OTC Market Growth Rebounds to 7.3% in 2023
  • 4/8/2024Boehringer Ingelheim and Sino Biopharm Enter Strategic Deal to Develop...
  • 4/8/2024Over 11M Chinese Residents Benefited from Major Disease Insurance in 2...
  • 4/8/2024NMPA Announces OTC Switch of Bismuth Potassium Citrate Capsules
  • 4/5/2024China Continues to Crackdown on Monopoly and Unfair Market Practices i...
  • 4/5/2024Recent Official Changes and Executive Moves
  • 4/5/2024Foreign Investors Fled Chinese Biotech After the Pandemic. They Still ...
  • 4/4/2024Rohto and Mitsui to Buy TCM Company for $590M
  • 4/3/2024Genmab A/S to Acquire ADC Developer ProfoundBio for $1.8B Cash
  • 4/3/2024What To Know About Jiyoutai - China's First Potential Ozempic Challeng...
  • 4/2/2024NHC Holds the 2024 National Drug Administration Work Conference
  • 4/2/2024Aurisco Launches State-of-the-Art Manufacturing Facility for GLP-1 Pep...
  • 4/1/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trial D...
  • 4/1/2024Congress Targets Biotech Suppliers for Pentagon Watchlist Amid China S...
  • 4/1/2024CMS and Incyte Enter License Deal for Povorcitinib in China and SE Asi...
  • 3/30/2024JPO Launches Follow-On Procurement for the National Level Insulin VBP ...
  • 3/30/2024Recent Official Changes and Executive Moves
  • 3/30/2024NMPA Holds the 2024 National Drug Regulatory Policy and Regulation Wor...
  • Page:7/333 Total number of articles:9986: [First][<<] [5] [6] [7] [8] [9] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group